Optilume™ BPH Catheter System in Men With Symptomatic BPH

To be considered for this study, you need to be a male between 50 and 80 years old, experiencing noticeable symptoms from an enlarged prostate (BPH). Your symptoms should be fairly significant, as measured by a special symptom score, and you should have a urine flow rate within a specific range, showing your urine stream isn't too strong or too weak. Your prostate size also needs to be between certain limits, and you should have had trouble with, couldn't take, or didn't want standard BPH medicines.

There are also some reasons why you wouldn't be able to join. For example, if you can't or don't want to sign the consent form or attend all follow-up appointments, or if you're not willing to avoid sex or use contraception for some time after the treatment. You also can't have certain other conditions, such as a history of prostate or bladder cancer, recent infections, other bladder problems, or previous prostate surgeries or similar treatments.

If you decide to take part, you'll first have screenings to ensure you meet all the study requirements. Once confirmed, you'll be randomly assigned to either receive the Optilume treatment or a sham (dummy) procedure. The Optilume treatment involves a catheter system that gently opens the urethra. You'll have regular follow-up appointments and tests over a period to check how you're doing, how your symptoms are changing, and to monitor for any side effects. These assessments might include answering questionnaires, having urine flow tests, and other examinations to track your progress. The specific number of visits and their duration will be explained in detail by the study team, but generally, studies like this involve multiple appointments over several months to a year or more to fully assess the long-term effects.